The two-in-one pill that prevents HIV infection

Image Source: Bhekisisa

Pre-exposure prophylaxis (PrEP) is a preventive strategy involving a daily pill that combines two antiretroviral medications to significantly reduce the risk of HIV infection.

Studies have demonstrated that consistent use of PrEP can lower the risk of contracting HIV by up to 96%.

Recognizing its efficacy, countries like Kenya and South Africa have initiated plans to offer PrEP to populations at higher risk, including young women.

This proactive approach aims to curb new HIV infections and is a critical component in the global fight against the AIDS epidemic.

For a more in-depth look at PrEP and its implementation in Africa, read the full article on Bhekisisa.